Posts by author
Adriana Albini
AI in Cancer Care: an overview
The first webinar on AI in Cancer Care was chaired by Eduardo Farina, Radiology Resident at UNIFESP (Federal University of São Paulo, Brazil) and AI Developer for healthcare at DASA (da América SA), SP, Brazil, who welcomed everyone and introduced…
Telemedicine In Cancer Care: Treatment, Tele-Oncology and Integrated Cancer Care
This webinar took place on 9 November 2022 as part of the Telemedicine Project Phase 2, developed by SPCC in collaboration with the American Society of Clinical Oncology (ASCO). It was chaired by Sana Al Sukhun, consultant in Medical Oncology/Hematology,…
Digital Solutions in Cancer Care: from Prevention to Diagnosis
Held on 12 October 2022, this was the first of the four live webinars in Phase 2 of the Telemedicine Educational Project developed by SPCC in collaboration with the American Society of Clinical Oncology (ASCO). Subtitled, “The Implementation and Integration…
Michael Sporn: A pioneer in prevention and a unique and special friend
Michael B. Sporn, an internationally recognised cancer researcher who was one of the discoverers of the tumour growth factor TGF beta and a strong advocate of Cancer Prevention, died on September 29, 2022 at his home in Tunbridge, Vermont. He…
Born to be walkers? How to stay healthy in a sedentary world
Humans have been endurance runners and walkers for at least 2 million years. Walking and running are our two main gaits. Whether we are more predisposed for the former or the latter is under debate. Studies carried out in the…
Telemedicine on the path to personalised treatment
Telemedicine has been defined as the use of telecommunications technology to deliver health care to populations with limited access to care. However, its increased adoption in the past couple of years, triggered by the Covid-19 pandemic and the constant development…
Telemedicine and diagnosis
The adoption of telemedicine and its range of applications grew exponentially in the early days of the Covid-19 pandemic, and the general consensus now is that it is here to stay, albeit perhaps with a more hybrid bias of in-person…
Cancer & Covid: Prevention and Treatment including Monoclonal Antibodies (MoABs) 2022
Introduction Among the most crucial problems caused by Covid-19 pandemics are the difficultyin the management of chronic diseases, the comorbidities, the impact on life expectancy, the search for therapy and prevention, the host interactions with the vaccines. Cancer patients constitute…
Telemedicine in the cancer continuum: Lessons from the Covid area and progress towards oncological prevention
Although telemedicine was to various degrees already in existence, with the Covid-19 pandemic it suddenly became a must, prompted by lockdown regulations and fear of contagion. Solutions had to be found and implemented quickly, and changes in the delivery of…
Interstitial Lung Disease (ILD) as adverse event
Interstitial lung disease (ILD) is a collective term used to describe a heterogeneous group of over 200 different non-infectious diseases affecting the lung parenchyma, that are characterised by nonspecific clinical, radiological, and pathological patterns. Identifiable causes of ILD include infections…